Supply of Material Sample Clauses

Supply of Material. 10.01 Licensor shall provide, or shall cause its Affiliates to provide (i) Licensor Material in possession of Licensor as of the Effective Date at the request of Licensee, to the extent that it is possible for Licensor to so provide and (ii) cGMP Compound and Non-cGMP Compound from among existing stocks as of the Effective Date. The Parties acknowledge that Licensor has in its possession approximately 7.9 kilograms of Compound manufactured in accordance with cGMP (“cGMP Compound”) and approximately 35 kilograms of Compound manufactured not in accordance with cGMP (‘‘Non-cGMP Compound”). Licensor agrees to sell to Licensee pursuant to a one-time purchase order delivered by Licensee to Licensor up to such amount of cGMP Compound as it may now have in its possession and to transfer to Licensee at no cost up to five (5) kilograms of Non-cGMP Product. Promptly following execution and delivery of this Agreement, Licensor shall take stock of its supply of cGMP Compound and inform Licensee of the quantity on hand. 10.02 Licensee shall submit one-time purchase order for cGMP Compound within ninety (90) days after the Effective Date to Licensor for fulfillment out of stock on hand at the time of the Effective Date of this Agreement. After consultation with Licensee, Licensor shall reasonably decide storage conditions, out-bound quality testing, ordering lead times, shipping methods, packaging, transit insurance and the like. cGMP Compound shall be delivered on the basis of Ex Works (Incoterms 2000), Licensor’ manufacturing site in Japan. All cGMP Compound delivered pursuant to this Agreement shall conform to the Specifications and shall have been manufactured in compliance with all applicable laws and cGMPs. Licensor shall cooperate with Licensee by providing access to and copies of such manufacturing and quality records directly related to cGMP Compound supplied pursuant to Section 10.01 as Licensee may reasonably require in connection with the clinical development of the Product including providing Licensee an opportunity, to be exercised in Licensee’s discretion, to audit Licensor’s manufacturing records regarding the production of cGMP Compound during ordinary business hours of Licensor but such access and audit shall not be allowed more than once respectively, nor shall they be a11owed at all after the filing of the first NDA. 10.03 In the event that any facilities, operations and laboratories of Licensor or any of [***] = Portions of this exhibit have been omi...

Supply of Material. The Bank may supply the Merchant with promotional material for the System, and the Merchant may at its discretion display at the Premises any of the material supplied by the Bank.

Supply of Material. Biogen shall provide the Institution, at no charge, with such quantities of the Product or placebo and other material, equipment or goods as may be required for a Trial and as Biogen may elect to make available (the Material). The Institution shall have no liability for any failure to fulfill its obligations as a result of the unavailability of the Material. The Institution shall use the Material only pursuant to and in accordance with the Protocol. The Institution shall not use, and shall not permit an Investigator to use, the Material for any other purpose without the prior written consent of Biogen. The supply terms of the Material, including the relevant financial terms, are included in Schedule A hereto. The Institution shall treat, handle, use and maintain, as applicable, the Material with the degree of care used for its own property and in accordance with the instructions of Biogen or its agents at any time. At the conclusion or termination of the Trial, the Institution shall account for all quantities used of the Material and, unless otherwise agreed in writing by the parties, shall return or otherwise dispose of all remaining Material in accordance with the instructions of Biogen or its agents.

Supply of Material. 3.1 In the case of an Outdoor Campaign where advertisements are to be displayed in a traditional (non- digital) format, all Advertisement Copy and Artwork (subject to any other terms specified in the Order) is to be delivered, carriage paid and at your risk, to us at the place(s) and within the time specified in the Order or otherwise communicated to you (and if no time is specified in the Order or otherwise communicated to you, no later than four (4) weeks prior to the Start Date). Subject to clause 3.3 of these Outdoor T&Cs, all Advertisement Copy shall be printed and shall be supplied to us in accordance with the Production Specifications for the relevant traditional media Sites. 3.2 In the case of an Outdoor Campaign where advertisements are to be displayed in a digital format, all Advertisement Copy and Artwork (subject to any other terms specified in the Order) is to be delivered in the specified electronic format to us within the time specified in the Order or otherwise communicated to you (and if no time is specified in the Order or otherwise communicated to you, no later than four (4) weeks prior to the Start Date) by the specified delivery method. Subject to clause 3.3 of these Outdoor T&Cs, all Advertisement Copy shall be supplied to us in accordance with the Production Specifications for the relevant digital media Sites. 3.3 If the Order includes the provision of Production Services by us then you will provide all necessary Artwork and any other information or detail to us by the Copy Deadline. If we are providing Design in accordance with clause 4 of these Outdoor T&Cs, you will provide all necessary Artwork (if any) and any other information or detail to us not less than two (2) weeks prior to the Copy Deadline (excluding any elements to be created by us if we are undertaking Design pursuant to clause 4 of these Outdoor T&Cs). You will supply any imagery print ready (at least 300 dpi) and any illustrations (including logos) in Vector format. 3.4 To the extent that: 3.4.1 any Advertisement Copy delivered to us does not comply with all relevant Production Specifications; or 3.4.2 any Advertisement Copy or Artwork is not delivered in the specified electronic format or by the specified delivery method, then the Advertisement Copy or Artwork (as appropriate) will be deemed not to have been delivered in accordance with this clause 3 of these Outdoor T&Cs. The Parties acknowledge that an approval or acceptance of Advertisement Copy or Artwork by us ...

Supply of Material. OPKO will, **** transfer to TESARO in accordance with the Technology Transfer Plan all quantities of API and Licensed Product in OPKO’s possession or control. To the extent such API or Licensed Product is identified as GMP-grade materials in the Technology Transfer Plan, OPKO represents that (i) since OPKO’s acquisition of such materials, OPKO has handled and stored such materials in accordance with current Good Manufacturing Practices as defined in the U.S. (“GMP”), and (ii) nothing has come to OPKO’s attention which leads it to believe that any such material has not been manufactured and stored in accordance with GMP, that it would not conform in all material respects to the applicable specifications or would not be fit for use in clinical trials pursuant to FDA guidelines and requirements. OPKO will provide copies of batch records and certificates of compliance in its possession with respect to such material. In addition, OPKO will, at the request of TESARO, require Merck & Co., Inc. to deliver the Hold Back API, as defined in the Asset Purchase Agreement, to TESARO or its designee, and to supply addition quantities of API to the extent consistent with Merck & Co., Inc.’s obligation under Section 7.11(b) of the Asset Purchase Agreement on terms to be approved by TESARO.

Supply of Material a) All Advertisement Copy (subject to any other terms in the Booking Confirmation) is to be delivered carriage paid and shall be supplied to the Contractor at the place(s) and within the time specified in the Booking Confirmation. All Advertisement Copy shall be produced and supplied to the Contractor in accordance with the Production Specifications. b) In the event that the Parties agree that the Contractor will undertake production of Advertisement Copy, then the Principal shall adhere to the Production Specifications and provide all detail necessary to allow such production to take place within the necessary timeframe. c) The Contractor shall be supplied with Advertisement Copy in accordance with the Production Specifications so as to enable the Contractor to maintain the display in good condition. d) Should the Principal fail to deliver Advertisement Copy in accordance with this Clause 4 the Contractor is not obliged to display the undelivered Advertisement Copy but the Principal shall, nonetheless, be liable to pay the corresponding Fees. The Contractor will use reasonable endeavours to display the undelivered Advertising Copy but without any commitment to meet the In Charge Date. e) A part delivery of the Advertisement Copy or a delivery not meeting the Production Specification or the provisions of this Clause 4 shall be deemed to be no delivery for the purposes of this Clause. f) Delivery of Advertisement Copy shall not be deemed to have been made until the relevant posting instructions have been given to and received by the Contractor. g) Any Advertising copy used during a campaign shall be disposed of in such manner as the Contractor shall decide, unless agreed otherwise at the time of Booking confirmation.

Supply of Material. CureVac will use Commercially Reasonable Efforts to supply to CRISPR, its Affiliates and Sublicensees the Materials set forth in Attachment C hereof. CRISPR will use such Materials only in accordance with the Work Plan as set forth in Attachment D and otherwise in accordance with the terms and conditions of this Agreement and will not reverse engineer or chemically analyze the Material except as expressly provided for in the Work Plan.

Supply of Material. Novartis will make available for pick up by AVEO the material and associated documentation identified on Exhibit A (the “Material”) within [**] after the later of (i) the Agreement Effective Date, or (ii) the date that AVEO provides all information and data reasonably necessary to transfer the Material in compliance with applicable law and/or cGMP (to the extent applicable); provided, however, notwithstanding the foregoing, and to the extent required by cGMP and the Parties’ respective Quality Assurance functions, cGMP Material will be transferred only following the execution of a commercially reasonable Quality Agreement between the Parties (as described below). The Material will be transferred Ex Works (Incoterms 2010) and except as provided on Exhibit A, is transferred “as is” and without representation or warranty of any kind and Novartis disclaims any implied warranties of merchantability or fitness for a particular purpose with respect to the Material; provided, however, that Novartis represents that, with respect to materials manufactured in accordance with cGMP, Novartis handled, stored and transported, and, until it is picked up by AVEO, will continue to handle, store and transport, the Material in accordance with cGMP for biological products. The Parties will enter into a commercially reasonable Quality Agreement with respect to the cGMP Material following the execution of this Agreement. Novartis will share with AVEO all material safety data sheets and customs value information that is reasonably available to Novartis, including without limitation Licensed Antibodies-specific information, as is reasonably necessary to permit AVEO to pick up the Material. AVEO will be solely responsible for any re-testing associated with the Material prior to use. Upon pick up by AVEO, Novartis will have no further obligation to replace lost or damaged material or to provide additional services with respect to such Material.

Supply of Material. BTT shall supply one hundred percent (100%) of Somaxon's requirements of the Product for clinical trial purposes. The price for such supply of Products shall equal the direct costs from third parties charged to BTT, including, but not limited to, the costs charged by Patheon Inc. ("Patheon") and the manufacturer of the active product ingredient, and shipping charges, without xxxx-up in all cases. BTT shall cooperate in good faith with Somaxon in its efforts to negotiate and establish a direct supply agreement with Patheon and any alternative supplier requested by Somaxon, in each case, for the supply of commercial quantities of Products.

Supply of Material. (a) SiTech hereby agrees to manufacture for, and deliver exclusively to Mentor, and Mentor agrees to purchase from SiTech, such quantities of the Materials to meet Mentor requirements based upon such written purchase orders and forecasts provided Pursuant to Section 2.3 hereof. In the event that Mentor's requirements differ significantly (by more than 10%) from the forecasts, Mentor will promptly notify SiTech of the fact and of the amount of such variance, and SiTech shall use its best efforts to accommodate any variance upon receiving notice thereof from Mentor. The parties hereto acknowledge and agree that SiTech may manufacture or sell other products to any third party upon the prior written consent of Mentor, which consent may be withheld by Mentor at Mentor's sole and absolute discretion. (b) Mentor shall be provided with a list of raw materials and finished goods inventory on a quarterly basis. Such list shall reflect the status of SiTech's inventory at the end of each calendar quarter sufficient to assure that Mentor shall have a three (3) month supply of the materials to be purchased by Mentor pursuant to the terms of this Agreement (the "Minimum Inventory Level"). Mentor shall have the right, but not the obligation, to conduct an annual audit of SiTech, at Mentor's expense, to satisfy itself that such Minimum Inventory Level is being met. In the event that Mentor's audit or any SiTech Quarterly report shall reveal that SiTech has not maintained the Minimum Inventory Level for each necessary raw material, Mentor may, at its sole option, purchase a three (3) month supply of any such raw material and store such raw material at SiTech's facility. SiTech shall reimburse Mentor for Mentor's actual cost for such raw materials upon SiTech's use of the raw material purchased by Mentor.